Details for New Drug Application (NDA): 074220
✉ Email this page to a colleague
NDA 074220 describes CORMAX, which is a drug marketed by Hikma and is included in one NDA. Additional details are available on the CORMAX profile page.
The generic ingredient in CORMAX is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
The generic ingredient in CORMAX is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 074220
| Tradename: | CORMAX |
| Applicant: | Hikma |
| Ingredient: | clobetasol propionate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 074220
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 0.05% | ||||
| Approval Date: | May 16, 1997 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
